A GMP-compliant manufacturing method for Wharton’s jelly-derived mesenchymal stromal cells
Abstract Background Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) hold great therapeutic potential in regenerative medicine. Therefore, it is crucial to establish a Good Manufacturing Practice (GMP)-compliant methodology for the isolation and culture of WJ-MSCs. Through comprehensive rese...
| Published in: | Stem Cell Research & Therapy |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-05-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-024-03725-0 |
